Your browser doesn't support javascript.
loading
Early sequential changes in serum markers of acute pancreatitis induced by endoscopic retrograde cholangiopancreatography.
Lempinen, Marko; Stenman, Ulf-Håkan; Halttunen, Jorma; Puolakkainen, Pauli; Haapiainen, Reijo; Kemppainen, Esko.
Afiliação
  • Lempinen M; Second Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland.
Pancreatology ; 5(2-3): 157-64, 2005.
Article em En | MEDLINE | ID: mdl-15849486
ABSTRACT
BACKGROUND/

AIMS:

Trypsinogen activation is thought to play a crucial role in the pathogenesis of acute pancreatitis (AP). Our aim was to characterize the very early sequential changes of trypsinogen-1, trypsinogen-2, the trypsin-2-alpha1-antitrypsin complex (T2-AAT), and pancreatic secretory trypsin inhibitor (PSTI) in serum from patients with pancreatitis induced by endoscopic retrograde cholangiopancreatography (ERCP), a model for studying the early phase of the disease in humans. PATIENTS AND

METHODS:

The study population consisted of 659 consecutive patients with 897 ERCP procedures. Blood samples were obtained before and at different time points after the procedure. The serum concentrations of trypsinogen-1 and trypsinogen-2, PSTI and T2-AAT were determined by time-resolved immunofluorometric assays.

RESULTS:

ERCP-induced pancreatitis developed after 50 of the 897 ERCP procedures (5.6%). Sixty-one randomly selected ERCP patients without post-ERCP pancreatitis served as controls. Trypsinogen-1 and trypsinogen-2 showed an equally steep increase during the two first hours after ERCP in patients developing AP, but trypsinogen-1 decreased more rapidly than trypsinogen-2, which remained elevated during the 5-day study period. Serum PSTI also increased rapidly whereas T2-AAT increased more slowly peaking at 24 h. In patients developing post-ERCP pancreatitis the median concentration of trypsinogen-1 was markedly higher than in the controls already before the ERCP procedure. In the control group the concentrations of trypsinogen-1, trypsinogen-2, PSTI and T2-AAT did not change significantly.

CONCLUSIONS:

The rapid increase of trypsinogen-1 and trypsinogen-2 and PSTI in the early phase of AP suggests that release of pancreatic enzymes is the initial event while the delayed increase of T2-AAT may reflect that the capacity of the intrapancreatic PSTI-based inhibitory mechanism has been exhausted.
Assuntos
Buscar no Google
Bases de dados: MEDLINE Assunto principal: Pancreatite / Tripsinogênio / Alfa 1-Antitripsina / Colangiopancreatografia Retrógrada Endoscópica / Peptídeos e Proteínas de Sinalização Intercelular Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Screening_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Pancreatology Assunto da revista: ENDOCRINOLOGIA / GASTROENTEROLOGIA Ano de publicação: 2005 Tipo de documento: Article País de afiliação: Finlândia
Buscar no Google
Bases de dados: MEDLINE Assunto principal: Pancreatite / Tripsinogênio / Alfa 1-Antitripsina / Colangiopancreatografia Retrógrada Endoscópica / Peptídeos e Proteínas de Sinalização Intercelular Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Screening_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Pancreatology Assunto da revista: ENDOCRINOLOGIA / GASTROENTEROLOGIA Ano de publicação: 2005 Tipo de documento: Article País de afiliação: Finlândia